Skip to main content
. 2022 Apr 23;36(11):1511–1520. doi: 10.1097/QAD.0000000000003244

Fig. 2.

Fig. 2

Virologic suppression on bictegravir/emtricitabine/tenofovir alafenamide at last on-treatment visit by last observation carried forward (LOCF).